Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
Teva
Baxter
Cantor Fitzgerald
Cerilliant
Healthtrust
Farmers Insurance
Fish and Richardson

Generated: April 21, 2018

DrugPatentWatch Database Preview

CALCIJEX Drug Profile

« Back to Dashboard

When do Calcijex patents expire, and what generic alternatives are available?

Calcijex is a drug marketed by Abbvie and is included in one NDA. There are three patents protecting this drug.

The generic ingredient in CALCIJEX is calcitriol. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the calcitriol profile page.
Drug patent expirations by year for CALCIJEX
Medical Subject Heading (MeSH) Categories for CALCIJEX
Synonyms for CALCIJEX
(1?,3?,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol
(1alpha,3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-5-hydroxy-1,5-dimethyl-hexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
(1R,3S,Z)-5-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol
(1R,3S,Z)-5-(2-((1R,3aS,7aR,E)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol
(1R,3S)-5-{2-[(1R,3aS,7aR)-1-((R)-5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol
(1S,3R,5Z,7E)-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(1S,3R,5Z,7E)-9,10-secocholesta-5,7,10-triene-1,3,25-triol
(1S,3R,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trienetriol
(5Z,10-secocholesta-5,7,10(19)-triene-1.alpha.,3.beta.,25-triol
(5Z,7E)-(1S,3R)-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
(5Z,7E)-(1S,3R)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1-alpha,3-beta,25-triol
(5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta,25-triol
1 alpha,25-Dihydroxyvitamin D3
1-alpha-25-dihydroxyvitamin D3
1-alpha,-1,25-Dihydroxyvitamin D3
1-alpha,25-Dihydroxycholecalciferol
1-alpha,25-Dihydroxyvitamin D3
1,25 (OH)2 D3
1,25 Dihydroxycholecalciferol
1,25-(OH)2-D3
1,25-(OH)2D3
1,25-DHCC
1,25-dihydroxy vitamin D3
1,25-dihydroxy-20-epi-Vitamin D3
1,25-DIHYDROXYCHOLECALCIFEROL
1,25-Dihydroxycholecaliferol
1,25-Dihydroxyvitamin D
1,25-Dihydroxyvitamin D3
1,25(OH)2-20epi-D3
1,25(OH)2D3 & CD4
1,25(OH2)D3
1,25D3
1.Alpha.,25-Dihydroxy-26,27-hexadeuterovitamin D3
1.alpha.,25-dihydroxycholecalciferol
1.alpha.,25-Dihydroxyvitamin D(sub 3)
1|A,25-Dihydroxyvitamin D3
1000873-74-4
125338-24-1
1a,25-(OH)2D3
1a,25-Dihydroxycholecalciferol
1a,25-Dihydroxyvitamin D3
1alpha 25-dihydroxycholecalciferol
1alpha,25 dihydroxyvitamin D(3)
1alpha,25-Dihydroxycholecalciferol
1alpha,25-Dihydroxyvitamin D
1alpha,25-Dihydroxyvitamin D3
1alpha,25-dihydroxyvitamin D3 / 1alpha,25-dihydroxycholecalciferol / calcitriol
1alpha,25-Dihydroxyvitamin D3, >=97.0% (HPLC)
1alpha,25-Dihydroxyvitamin D3, >=99% (HPLC)
1alpha,25(OH)2-D3
1alpha,25(OH)2D3
1db1
20-epi-1alpha,25-dihydroxycholecaliferol
222C063
25-dihydroxycholecalciferol
32222-06-3
62019-EP2292592A1
62019-EP2298772A1
62019-EP2308828A2
62019-EP2308839A1
69878-52-0
9,?10-?SECOCHOLESTA-?5Z,?7E,?10(19)-?TRIENE-?1ALPHA,?3BETA,?25-?TRIOL
9,10-seco(5Z,7E)-5,7,10(19)-cholestatriene-1alpha, 3beta, 25-triol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatriene-1alpha,3beta,25-triol
9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1.alpha.,3.beta,.5Z,7E)-
9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1.alpha.,3.beta,.5Z,7E)- & CD4
9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1alpha,3beta,5Z,7E)-
AB00639957_07
AB00639957-06
AC-1859
AC1NQX1S
ACT06832
AKOS015961898
Ambap32222-06-3
Asentar
BC208534
BCBcMAP01_000160
BCP9000474
BCPP000304
BDBM50200182
BML2-E03
BRD-K27316855-001-06-7
BSPBio_001287
C01673
calcitriol
Calcitriol (API-31543, drug-induced alopecia), Cytotech Labs
Calcitriol (chemotherapy-induced alopecia)
Calcitriol (chemotherapy-induced alopecia), Cytotech Labs
Calcitriol (JAN/USP/INN)
Calcitriol (Rocaltrol)
Calcitriol [USAN:INN:BAN:JAN]
Calcitriol [USAN:USP:INN:BAN:JAN]
Calcitriol, European Pharmacopoeia (EP) Reference Standard
Calcitriolum
Calcitriolum [INN-Latin]
Cas Number 32222-06-3
CAS-32222-06-3
CCG-101001
CCRIS 5522
CD-2027
CHEBI:17823
CHEBI:93988
CHEMBL846
Cholecalci
Cholecalciferol, 1-alpha,25-dihydroxy-
CPD000466393
CS-0388
D00129
D0G2KU
D0T2PL
DB00136
Decostriol
Dihydroxyvitamin D3
DN 101
DN-101
DR002536
DSSTox_CID_2722
DSSTox_GSID_22722
DSSTox_RID_76700
DTXSID5022722
EINECS 250-963-8
FXC9231JVH
GMRQFYUYWCNGIN-NKMMMXOESA-N
GTPL2779
HMS1361A09
HMS1791A09
HMS1989A09
HMS2051F06
HMS2089N03
HMS2232D18
HMS3402A09
HSDB 3482
HY-10002
IDI1_033757
LMST03020258
LS-53093
MC-1288
MC1288
MFCD00867079
MLS000759536
MLS001424122
MolPort-002-045-698
NC00251
NCGC00161327-01
NCGC00161327-04
NSC-749776
NSC749776
OR109383
OR257675
OR257676
Panbonis
PubChem18818
PubChem19327
Ro 21-5535
Ro 215535
Ro-21-5535
Ro-215535
Rocaltrol
Rocaltrol (TN)
s1466
SC-17020
SCHEMBL3245
Silkis
SMR000466393
Soltriol
Spectrum5_002061
SR-01000946978
SR-01000946978-1
Synthetic vitamin D analog
Topitriol
Toptriol
Tox21_111988
U 49562
UNII-FXC9231JVH
Vectical
vit D
Vitamin D3, 1alpha, 25-Dihydroxy-
W-5161
ZINC100015048
ZX-AFC000310

US Patents and Regulatory Information for CALCIJEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-001 Sep 25, 1986 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-002 Sep 25, 1986 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-001 Sep 25, 1986 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-001 Sep 25, 1986 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CALCIJEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-001 Sep 25, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-002 Sep 25, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-002 Sep 25, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-001 Sep 25, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
QuintilesIMS
Queensland Health
Teva
Boehringer Ingelheim
Julphar
Johnson and Johnson
Cantor Fitzgerald
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.